Phase IIa proof of concept study of pipamperone/citalopram (PipCit) versus citalopram in the treatment of major depressive disorder (MDD) [depression].

Trial Profile

Phase IIa proof of concept study of pipamperone/citalopram (PipCit) versus citalopram in the treatment of major depressive disorder (MDD) [depression].

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2013

At a glance

  • Drugs Citalopram/pipamperone (Primary) ; Citalopram
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors PharmaNeuroBoost
  • Most Recent Events

    • 22 May 2013 Results reporting early and sustained response rates presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 30 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top